A natural choice for hemophilia B

descriptionPublicationkeyboard_double_arrow_right Article 05 Mar 2015 English Publisher:American Society of HematologyJournal:Blood, volume 125, pages 1,509-1,510 (issn: 0006-4971, eissn: 1528-0020,

Copyright policy )

Authors: Dwight D, Koeberl;

doi: 10.1182/blood-2015-01-622506

pmid: 25745178

A natural choice for hemophilia B

- Summary
- Subjects
- Metrics

Abstract

In this issue of Blood, Crudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that induced immune tolerance to factor IX (FIX) in a hemophilia B (HB) dog with previously formed anti-FIX inhibitor antibodies (IAs).

Related Organizations

Duke Medical Center
United States
Duke University
United States

Keywords

Factor IX, Male, Animals, Humans, Genetic Therapy, Hemophilia B

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average